Actavis, Formerly Watson, Sees 2013 Profit Growth

25.01.2013 - Actavis, the generic drugmaker previously known as Watson Pharmaceuticals, said on Friday that it expected earnings to rise at least 30% in 2013 as it expands globally, but its...